Keyword: Glenmark Pharmaceuticals
The Indian drugmaker’s hiring coup leaves Gilead without the oncology leader that oversaw its takeover of Kite Pharma and push into CAR-T.
Glenmark is rolling all of the new molecular entities in its pipeline into a separate U.S. company in an effort to speed the programs to market.
Intellia clinical head to be Casebia’s first CMO; Ferring CSO to take over for retiring board president; and Harpoon names new CFO and CSO.
A hospital in India is accused of misleading people into joining a clinical trial of a Glenmark Pharmaceuticals painkiller without their consent.